SCHEMBL993670

SCHEMBL993670

CC(=O)Oc1ccc(I)c(C)c1N(C)C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ NCEH1 Q6PIU2 3/20 0.33
▸ ACHE P22303 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ PAX8 Q06710 1/20 0.32
▸ CFD P00746 1/20 0.31
▸ ELANE P08246 1/20 0.31
▸ SNCA P37840 1/20 0.31
▸ PTPN1 P18031 1/20 0.31
▸ MTNR1A P48039 1/20 0.30
▸ MTNR1B P49286 1/20 0.30
▸ TOP1 P11387 1/20 0.30
▸ BRD4 O60885 1/20 0.30
▸ PIM1 P11309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27588996 0.73 ACHE (0.38) TSHRACHEKDM4EALDH1A1GAA
SCHEMBL992563 0.71 TSPO (0.44) TSHRSMN1; SMN2ACHEKDM4EALDH1A1
SCHEMBL27427104 0.69 AAK1 (0.36) SMN1; SMN2NCEH1KDM4EALDH1A1GAA
SCHEMBL5736205 0.68 ACHE (0.40) TSHRSMN1; SMN2ACHEKDM4EALDH1A1
SCHEMBL992564 0.68 RAB9A (0.50) SMN1; SMN2ALDH1A1RAB9APAX8ELANE
SCHEMBL24195886 0.67 KDM4E (0.47) TSHRACHEKDM4EALDH1A1GAA
SCHEMBL29837226 0.66 PAX8 (0.41) TSHRSMN1; SMN2ALDH1A1GAARAB9A
SCHEMBL27630345 0.66 BRD4 (0.42) TSHRSMN1; SMN2KDM4EALDH1A1RAB9A
SCHEMBL22134679 0.66 ALDH1A1 (0.35) NCEH1KDM4EALDH1A1GAAPAX8
SCHEMBL28943941 0.66 ACHE (0.37) TSHRACHEKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011011483-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-01-27 — — WO disclosed
Send feedback